Share-based compensation and stockholders' equity (Tables)

9 Months Ended

Sep. 30, 2024

Stockholders' Equity Note [Abstract]

Schedule of Stock-based Compensation Expense

Share-based compensation expense, net of forfeitures was recorded in the following financial statement line items:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Cost of Commercial Product sales	$	—	$	—	$	—	$	0.1
Cost of MCM Product sales	0.3		1.0		1.6		3.5
Cost of Bioservices	(0.1)		0.2		0.2		0.8
R&D	—		0.6		1.0		1.7
Selling, general and administrative	2.1		2.2		10.9		13.0
Total share-based compensation expense	$	2.3	$	4.0	$	13.7	$	19.1

Schedule of Stockholders' Equity Note, Warrants or Rights

As of September 30, 2024, the Company had the following Warrants outstanding to acquire shares of its common stock:

	Warrants Outstanding	Range of Exercise  Price per Share	Expiration Date
Warrants issued related to the Term Loan Agreement	2.5	$9.88 - $15.72	August 2029
Total	2.5

Schedule of Accumulated Other Comprehensive Income (Loss)

The following table includes changes in accumulated other comprehensive income (loss), net of tax by component:

	Defined Benefit Pension Plan		Derivative Instruments		Foreign Currency  Translation Adjustments		Total
Balance at December 31, 2023	$	—	$	—	$	(5.7)	$	(5.7)
Other comprehensive income before reclassifications	—		—		0.2		0.2
Net current period other comprehensive income	—		—		0.2		0.2
Balance at March 31, 2024	$	—	$	—	$	(5.5)	$	(5.5)
Other comprehensive income (loss) before reclassifications	—		—		—		—
Net current period other comprehensive loss	—		—		—		—
Balance at June 30, 2024	$	—	$	—	$	(5.5)	$	(5.5)
Other comprehensive income (loss) before reclassifications	—		—		(1.8)		(1.8)
Net current period other comprehensive loss	—		—		(1.8)		(1.8)
Balance at September 30, 2024	$	—	$	—	$	(7.3)	$	(7.3)
Balance at December 31, 2022	$	3.5	$	6.2	$	(6.6)	$	3.1
Other comprehensive loss before reclassifications	—		(4.4)		(0.1)		(4.5)
Amounts reclassified from accumulated other comprehensive income	—		2.4		—		2.4
Net current period other comprehensive loss	—		(2.0)		(0.1)		(2.1)
Balance at March 31, 2023	$	3.5	$	4.2	$	(6.7)	$	1.0
Other comprehensive income before reclassifications	—		1.2		2.6		3.8
Amounts reclassified from accumulated other comprehensive loss	(3.5)		(2.9)		—		(6.4)
Net current period other comprehensive income (loss)	(3.5)		(1.7)		2.6		(2.6)
Balance at June 30, 2023	$	—	$	2.5	$	(4.1)	$	(1.6)
Other comprehensive income (loss) before reclassifications	—		0.9		1.2		2.1
Amounts reclassified from accumulated other comprehensive income (loss)	—		(3.1)		—		(3.1)
Net current period other comprehensive income (loss)	—		(2.2)		1.2		(1.0)
Balance at September 30, 2023	$	—	$	0.3	$	(2.9)	$	(2.6)

Schedule of Comprehensive Income (Loss)

The tables below present the tax effects related to each component of other comprehensive income (loss):

	Three Months Ended September 30,
	2024						2023
	Pretax		Tax Expense		Net of tax		Pretax		Tax Expense		Net of tax
Derivative instruments	$	—	$	—	$	—	$	(3.1)	$	0.9	$	(2.2)
Foreign currency translation adjustments	(1.8)		—		(1.8)		0.9		0.3		1.2
Total adjustments	$	(1.8)	$	—	$	(1.8)	$	(2.2)	$	1.2	$	(1.0)

	Nine Months Ended September 30,
	2024						2023
	Pretax		Tax Expense		Net of tax		Pretax		Tax Expense		Net of tax
Defined benefit pension plan	$	—	$	—	$	—	$	(4.1)	$	0.6	$	(3.5)
Derivative instruments	—		—		—		(8.0)		2.1		(5.9)
Foreign currency translation adjustments	(1.6)		—		(1.6)		2.9		0.8		3.7
Total adjustments	$	(1.6)	$	—	$	(1.6)	$	(9.2)	$	3.5	$	(5.7)